Biopharmaceutical
Biotechnology
Medical

Dynavax

2,825

$3.18
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.29 (-8.38%) Today
+$0.01 (+0.32%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Dynavax and other stocks, options, ETFs, and crypto commission-free!

About DVAX

Dynavax Technologies Corp. operates as a biopharmaceutical company, which engages in the discovery, development and commercialization of novel vaccines and immuno-oncology therapeutics. The firm focuses on leveraging the body's innate and adaptive immune responses through toll-like receptor stimulation. Read More It offers products for vaccines, cancer immunotherapy, and immune-mediated diseases. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Berkeley, CA.

CEO
Ryan Spencer
Employees
231
Headquarters
Emeryville, California
Founded
1996
Market Cap
273.22M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.43M
High Today
$3.69
Low Today
$3.12
Open Price
$3.51
Volume
1.36M
52 Week High
$8.19
52 Week Low
$1.80

Collections

Biopharmaceutical
Biotechnology
Medical
Pharmaceutical
Health
Cancer Prevention
Therapy
Technology

DVAX Earnings

-$0.65
-$0.43
-$0.22
$0.00
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected May 7, After Hours

People Also Bought

Viking Therapeutics

51,598

$4.31

-4.01%

Viking Therapeutics

51,598

$4.31

-4.01%

Novavax

38,641

$15.40

+11.11%

Micron Technology

48,215

$41.21

+0.29%

Nektar Therapeutics

4,592

$16.86

-1.29%

You May Also Like

IBCP
HUYA
DSM
EXR
MAAX
TERM
MUI
WLKP
FFEB
ACEL+
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy DVAX

Market Price$3.18
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell Dynavax stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up